PATENT CLAIM ANALYSIS

Application Number: 15891170
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "450000"]

Abstract:
Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Claim (Index 6):
The composition of  claim 1  wherein the agents are antineoplastic agents.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.11538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14352662', '14216605', '09122427', '10294474', '11018574']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7119663922980589
- 35 USC 102 Novelty (BERT): 0.5486923036208117
- Combined Prediction Score: 0.6956389834303341
- Mean Citation Score: 262.631952
- Max Citation Score: 433.29733
- Similarity Product: 260.5778679982144

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test